Literature DB >> 11037957

Meanings of dying at home for Chinese patients in Taiwan with terminal cancer: a literature review.

S T Tang1.   

Abstract

To maintain dignity, patients with terminal cancer must be able to do things in their own way, to make their own decisions, and to preside over their own dying. Among the tasks considered essential for patients with terminal cancer is deciding where they prefer to die. The actual place of death has been recognized in hospice care as indicating quality of care. Approximately two-thirds of patients with cancer, when asked about the preferred place of death, say they wish to die in their own homes. Patients with terminal cancer dying at home may find physical and emotional comfort there. Home is a place where people may feel safety and a sense of belonging. In dying at home, patients with terminal cancer also may have a greater chance to control their environment, more autonomy and privacy, and a sense of normality. In this article, special cultural meaning of dying at home for the Chinese patient and the family is reviewed. It is essential for health care professionals to understand Chinese cultural beliefs and values related to dying at home in order to provide culturally sensitive care for Chinese dying patients and their families and to enhance their sense of control over the unknown process of dying.

Entities:  

Mesh:

Year:  2000        PMID: 11037957     DOI: 10.1097/00002820-200010000-00007

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  13 in total

1.  A population-based study on the specific locations of cancer deaths in Taiwan, 1997-2003.

Authors:  Herng-Ching Lin; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

Review 2.  Factors influencing death at home in terminally ill patients with cancer: systematic review.

Authors:  Barbara Gomes; Irene J Higginson
Journal:  BMJ       Date:  2006-02-08

3.  Going home to die from surgical intensive care units.

Authors:  Yu-Chen Huang; Sheng-Jean Huang; Wen-Je Ko
Journal:  Intensive Care Med       Date:  2009-03-12       Impact factor: 17.440

4.  Patient Preferences versus Family Physicians' Perceptions Regarding the Place of End-of-Life Care and Death: A Nationwide Study in Taiwan.

Authors:  Chih-Yuan Shih; Wen-Yu Hu; Shao-Yi Cheng; Chien-An Yao; Ching-Yu Chen; Yen-Chun Lin; Tai-Yuan Chiu
Journal:  J Palliat Med       Date:  2015-04-30       Impact factor: 2.947

Review 5.  A cross-cultural comparison of hospice development in Japan, South Korea, and Taiwan.

Authors:  Anne P Glass; Li-Kuang Chen; Eunju Hwang; Yuzuho Ono; Lusine Nahapetyan
Journal:  J Cross Cult Gerontol       Date:  2010-03

6.  Treatment and Outcomes of Thrombolysis Related Hemorrhagic Transformation: A Multi-Center Study in China.

Authors:  Junfeng Liu; Yanan Wang; Jing Li; Shanshan Zhang; Qian Wu; Chenchen Wei; Ting Cui; Bo Wu; Joshua Z Willey; Ming Liu
Journal:  Front Aging Neurosci       Date:  2022-04-07       Impact factor: 5.750

7.  Effect of hospice care on quality indicators of end-of-life care among patients with liver cancer: a national longitudinal population-based study in Taiwan 2000-2011.

Authors:  Yee-Hsin Kao; Jui-Kun Chiang
Journal:  BMC Palliat Care       Date:  2015-08-19       Impact factor: 3.234

8.  How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study.

Authors:  Jack P Wang; Chen-Yi Wu; I-Hsuan Hwang; Chien-Hui Kao; Yi-Ping Hung; Shinn-Jang Hwang; Chung-Pin Li
Journal:  BMC Palliat Care       Date:  2016-01-08       Impact factor: 3.234

9.  Changes in living arrangements and mortality among older people in China.

Authors:  Zhixin Feng; Jane Falkingham; Xiaoting Liu; Athina Vlachantoni
Journal:  SSM Popul Health       Date:  2016-11-30

10.  Socioeconomic Differences and Trends in the Place of Death among Elderly People in China.

Authors:  Jiaoli Cai; Hongzhong Zhao; Peter C Coyte
Journal:  Int J Environ Res Public Health       Date:  2017-10-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.